Related Experiment Video

Updated: Jul 4, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
06:15

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation

Published on: November 10, 2023

Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients

Madhuri M Sopirala1, Amy Pope-Harman, David R Nunley

  • 1Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Medical Center, Columbus, OH 43210, USA. madhuri.sopirala@osumc.edu

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|June 28, 2008
PubMed

Insights

Multidrug-resistant Acinetobacter baumannii pneumonia is a serious threat in lung transplant recipients. Prior broad-spectrum antibiotic use increases infection risk, necessitating further research into optimal prevention and treatment strategies.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Transplantation Medicine

Background:

  • Lung transplant recipients are vulnerable to opportunistic infections.
  • Multidrug-resistant (MDR) Acinetobacter baumannii poses a significant challenge in immunocompromised patients.

Observation:

  • This study details 6 cases of MDR Acinetobacter baumannii pneumonia in lung transplant recipients.
  • Patients received treatments including imipenem, tigecycline, and colistimethate.

Findings:

  • Prior broad-spectrum antimicrobial therapy was identified as the primary risk factor for developing MDR Acinetobacter baumannii pneumonia.
  • Treatment outcomes varied significantly among the observed cases, highlighting the complexity of managing these infections.

Implications:

  • Effective preventive strategies are crucial for lung transplant recipients at risk of MDR Acinetobacter baumannii.
  • Further research is needed to establish optimal therapeutic approaches for this challenging pathogen in lung transplant recipients.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...